BioLife Solutions, Inc.BLFSNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
103.73%
↑ 196% above average
Average (39q)
-107.55%
Historical baseline
Range
High:819.53%
Low:-2931.82%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 103.73% |
| Q2 2025 | -1266.42% |
| Q1 2025 | -187.88% |
| Q4 2024 | 188.90% |
| Q3 2024 | 57.42% |
| Q2 2024 | -11.11% |
| Q1 2024 | 55.78% |
| Q4 2023 | 14.79% |
| Q3 2023 | 42.77% |
| Q2 2023 | -18.59% |
| Q1 2023 | -26.19% |
| Q4 2022 | -12.73% |
| Q3 2022 | -3.90% |
| Q2 2022 | 20.43% |
| Q1 2022 | 39.74% |
| Q4 2021 | -62.95% |
| Q3 2021 | -144.98% |
| Q2 2021 | -364.32% |
| Q1 2021 | 79.28% |
| Q4 2020 | -280.02% |
| Q3 2020 | -2931.82% |
| Q2 2020 | -88.11% |
| Q1 2020 | 132.20% |
| Q4 2019 | -92.46% |
| Q3 2019 | -164.96% |
| Q2 2019 | 87.17% |
| Q1 2019 | -52.92% |
| Q4 2018 | -12.72% |
| Q3 2018 | -6.99% |
| Q2 2018 | 819.53% |
| Q1 2018 | 164.09% |
| Q4 2017 | -573.98% |
| Q3 2017 | 90.52% |
| Q2 2017 | 26.47% |
| Q1 2017 | 25.99% |
| Q4 2016 | 44.90% |
| Q3 2016 | 28.61% |
| Q2 2016 | -6.80% |
| Q1 2016 | -6.28% |
| Q4 2015 | -8.32% |